Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine if patients with NARES treated with montelukast
(Singulair) will have improved nasal symptom scores and reduced nasal eosinophils.